Effects of nano-curcumin on gene expression of insulin and insulin receptor
Weaam Gouda, Naglaa A. Hafiz, Lamiaa Mageed, Ahmed S. Alazzouni, Wagdy K. B. Khalil, Mie Afify, Mohamed D. E. Abdelmaksoud
Abstract
Open-access reader
Weaam Gouda, Naglaa A. Hafiz, Lamiaa Mageed, Ahmed S. Alazzouni, Wagdy K. B. Khalil, Mie Afify, Mohamed D. E. Abdelmaksoud
Abstract
Open-access reader
This study investigates the effects of nano-curcumin on gene expression of insulin and insulin receptor in diabetic rats. Forty female rats were divided into four groups (ten rats for each). The first group was non-diabetic rats acting as negative control and rats of the second group were rendered diabetic by STZ served as positive controls. The third one was induced diabetic and received oral Diamicron for 3 weeks. The fourth was rendered diabetic and administrated oral nano-curcumin for 3 weeks. A significant increase of blood glucose was showed in diabetic rats with significant reduction of insulin level compared to non-diabetic controls. The gene expression of insulin and insulin receptor were more significant in diabetic untreated rats compared to the control non-diabetic group. The induction of curcumin as well as Diamicron to diabetic rats normalized significantly their blood sugar level. Also, curcumin-treated rats indicated significant higher in gene expression of insulin and insulin receptor than positive and negative controls. The results suggest that nano-curcumin could be used as antidiabetic therapy, induced hypoglycemia, and increase the gene expression of insulin and insulin receptor in STZ-induced diabetic rats. More studies are needed to illustrate the definite mechanism of action of nano-curcumin concerning the upregulation of gene expression of the above-mentioned genes.
OpenAlex reports 35 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study investigates the effects of nano-curcumin on gene expression of insulin and insulin receptor in diabetic rats. Forty female rats were divided into four groups (ten rats for each). The first group was non-diabetic rats acting as negative control and rats of the second group were rendered diabetic by STZ served as positive controls. The third one was induced diabetic and received oral Diamicron for 3 weeks. The fourth was rendered diabetic and administrated oral nano-curcumin for 3 weeks. A significant increase of blood glucose was showed in diabetic rats with significant reduction of insulin level compared to non-diabetic controls. The gene expression of insulin and insulin receptor were more significant in diabetic untreated rats compared to the control non-diabetic group. The induction of curcumin as well as Diamicron to diabetic rats normalized significantly their blood sugar level. Also, curcumin-treated rats indicated significant higher in gene expression of insulin and insulin receptor than positive and negative controls. The results suggest that nano-curcumin could be used as antidiabetic therapy, induced hypoglycemia, and increase the gene expression of insulin and insulin receptor in STZ-induced diabetic rats. More studies are needed to illustrate the definite mechanism of action of nano-curcumin concerning the upregulation of gene expression of the above-mentioned genes.
Key concepts: Endocrinology, Internal medicine, Insulin, Curcumin, Diabetes mellitus, Insulin receptor, Hypoglycemia, Medicine